The National Drug Agency of Tunisia has introduced a new system allowing citizens and healthcare professionals to report any medicines or health products suspected of being non-compliant with standards, counterfeit, or adulterated. This move aims to enhance regulatory oversight and protect public health. The agency has made the service available to the general public, including patients, consumers, and healthcare professionals, encouraging them to report any concerns about the safety of a medicine or health product.
The agency has identified several indicators that warrant reporting, including unusual packaging, unfamiliar product appearance, unexpected side effects after use, and instances of sales outside authorized channels or at suspiciously low prices. The agency categorizes reportable cases into two main groups: non-compliant products, which are legally licensed but fail to meet technical specifications and quality standards, and counterfeit products, including those with misleading or false information about their identity, chemical composition, or origin.
To facilitate reporting, the National Drug Agency has established three direct channels for receiving notifications and reports. These include an online platform where users can complete an electronic form on the agency's official website, an email address where details of the report and relevant documents can be sent, and a postal address where formal reports can be deposited with the Ministry of Health's regulatory office.
The agency encourages reporters to provide as much information as possible about the product in question to expedite verification, including the product name, dosage, batch number, expiration date, and a description of the issue observed, as well as conditions of purchase. Reporters are also encouraged to attach clear images of the product and its packaging.
In a statement, the agency assured all stakeholders that the identity of reporters is protected and that the confidentiality of submitted data is guaranteed, noting that reports can be submitted anonymously. The agency emphasized the importance of public and professional vigilance, highlighting that prompt reporting of suspect products supports regulatory efforts to verify and limit the circulation of non-compliant or counterfeit medicines and health products.
The National Drug Agency's move is seen as a significant step towards enhancing the safety and quality of medicines and health products available in Tunisia. By engaging citizens and healthcare professionals in the reporting process, the agency aims to improve its ability to detect and respond to potential threats to public health. The agency's efforts are focused on ensuring that only safe and effective products are available on the market.
The agency's initiative has been welcomed by stakeholders, who see it as a positive development in the country's efforts to strengthen its regulatory framework and protect public health. The agency's commitment to transparency and accountability is seen as essential in building trust and confidence in the safety and quality of medicines and health products available in Tunisia.
Key points
- The National Drug Agency has established a formal mechanism for reporting suspect medicines and health products to enhance regulatory oversight and protect public health.
- The agency has identified several indicators that warrant reporting, including unusual packaging and unexpected side effects.
- Reporters can submit reports through an online platform, email, or postal address, and their identities are protected.
